임상 리스크 그루핑 솔루션 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Clinical Risk Grouping Solution Market Size, Share & Trends Analysis Report By Product (Software, Services), By Application (Population Health Management, Chronic Disease Management), By End Use, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,374,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,782,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,597,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

임상 리스크 그루핑 솔루션 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 임상 리스크 그루핑 솔루션 시장 규모는 2030년까지 16억 7,000만 달러에 달하며, 2024-2030년 CAGR은 13.13%로 확대할 것으로 예측됩니다.

이 시장에는 의료 환경에서 환자의 위험을 효과적으로 평가하고 관리하기 위해 고안된 다양한 툴와 기술이 포함되어 있습니다.

데이터 분석과 기술 발전은 시장을 발전시키는 데 있으며, 매우 중요합니다. 인공지능(AI)과 머신러닝(ML)을 임상 위험군 분류 솔루션에 통합하면 결과를 예측하는 능력이 크게 향상되어 의료 서비스 프로바이더가 더 나은 의사결정을 내릴 수 있게 됩니다.

의료기관이 비용을 절감하고 환자 결과를 개선하기 위해 노력하는 가운데, 종합적인 집단 헬스케어 솔루션에 대한 필요성이 점점 더 커지고 있습니다. 이러한 솔루션을 통해 의료 기관은 환자 데이터를 효과적으로 분석하여 고위험군 환자를 식별하고 예방 전략을 실행할 수 있습니다.

임상 리스크 그루핑 솔루션 시장 보고서 하이라이트

• 제품별로는 소프트웨어가 2023년 77.46%로 가장 큰 시장 점유율을 차지했습니다. 전자 의료 기록(EHR)과 고급 분석 툴의 사용이 증가함에 따라 환자를 임상적 위험에 따라 정확하게 분류하고 맞춤 치료 계획을 지원하며 환자 결과를 개선할 수 있는 소프트웨어 솔루션에 대한 수요가 증가하고 있습니다.
• 애플리케이션별로는 집단 헬스케어가 2023년 33.20%로 가장 큰 시장 점유율을 차지했습니다. 이 부문은 전자 의료 기록, 청구 데이터, 건강의 사회적 결정 요인과 같은 다양한 소스의 환자 데이터를 통합하여 고위험군 개인을 정확히 식별하고 전반적인 건강 결과를 개선하기 위해 맞춤형 개입을 고안합니다.
• 최종 사용처를 기준으로 병원 및 클리닉이 2023년 48.30%의 최대 매출 점유율로 시장을 장악했습니다. 이들 기관은 임상 리스크 그루핑 솔루션을 채택하여 건강 상태, 치료 요구 사항 및 잠재적 위험에 따라 환자를 분류하여 환자 관리를 개선하고 비용을 절감할 수 있는 맞춤 치료 계획을 수립할 수 있습니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 임상 리스크 그루핑 솔루션 시장의 변수, 동향, 범위

• 시장 계통 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 임상 리스크 그루핑 솔루션 시장 분석 툴
  • 업계 분석 - Porter's Five Forces 분석
  • PESTEL 분석

제4장 임상 리스크 그루핑 솔루션 시장 : 제품별 추정·동향 분석

• 세계의 임상 리스크 그루핑 솔루션 시장 : 제품별 대시보드
• 세계의 임상 리스크 그루핑 솔루션 시장 : 제품별 변동 분석
• 제품별 매출
• 소프트웨어
• 서비스

제5장 임상 리스크 그루핑 솔루션 시장 : 용도별 추정·동향 분석

• 세계의 임상 리스크 그루핑 솔루션 시장 : 용도별 대시보드
• 세계의 임상 리스크 그루핑 솔루션 시장 : 용도별 변동 분석
• 세계의 임상 리스크 그루핑 솔루션 시장 : 용도별 매출
• 집단건강관리
  • 시장 추산·예측 2018-2030년
• 만성질환 관리
  • 시장 추산·예측 2018-2030년
• 임상 의사결정 지원
  • 시장 추산·예측 2018-2030년
• 부정행위 탐지와 방지
  • 시장 추산·예측 2018-2030년
• 기타
  • 시장 추산·예측 2018-2030년

제6장 임상 리스크 그루핑 솔루션 시장 : 최종 용도별 추정·동향 분석

• 세계의 임상 리스크 그루핑 솔루션 시장 : 최종 용도별 대시보드
• 세계의 임상 리스크 그루핑 솔루션 시장 : 최종 용도별 변동 분석
• 최종 용도별 매출
• 병원·클리닉
• 외래 수술 센터
• 장기 케어 센터
• 기타

제7장 임상 리스크 그루핑 솔루션 시장 : 제품, 용도, 최종 용도별 지역 추정·동향 분석

• 지역 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년 :
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제8장 경쟁 구도

• 기업/경쟁의 분류
• 벤더 구도
  • 주요 판매 대리점 및 채널 파트너 리스트
  • 주요 기업의 시장 점유율 분석, 2023년
  • Conduent Inc.
  • HBI Solutions
  • 3M
  • Cerner(Oracle)
  • Optum Inc.
  • Reveleer
  • Nuance Communications, Inc.
  • Lightbeam
  • Health Catalyst

KSA

영문 목차

영문목차

Clinical Risk Grouping Solution Market Growth & Trends:

The global clinical risk grouping solution market size is anticipated to reach USD 1.67 billion by 2030 and is anticipated to expand at a CAGR of 13.13% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market encompasses various tools and technologies designed to assess and manage patient risk within healthcare settings effectively.

The progress made in data analytics and technology is crucial for propelling the market forward. Incorporating artificial intelligence (AI) and machine learning (ML) into clinical risk grouping solutions significantly improves their ability to predict outcomes, enabling healthcare providers to make better-informed decisions.

As healthcare providers strive to enhance patient outcomes while controlling expenses, the necessity for comprehensive population health management solutions has become increasingly important. These solutions empower healthcare organizations to analyze patient data effectively, pinpoint high-risk individuals, and implement preventive strategies.

Clinical Risk Grouping Solution Market Report Highlights:

• Based on product, software held the largest market share of 77.46% in 2023. The rising use of electronic health records (EHRs) and advanced analytics tools has driven the demand for software solutions to accurately classify patients according to their clinical risks, support personalized treatment plans, and enhance patient outcomes.
• Based on application, Population health management held the largest market share of 33.20% in 2023. This segment consolidates patient data from diverse sources, such as electronic health records, claims data, and social determinants of health, to pinpoint high-risk individuals and devise customized interventions to enhance overall health outcomes.
• Based on end use, hospitals and clinic dominated the market with the largest revenue share of 48.30% in 2023.These institutions employ clinical risk grouping solutions to classify patients according to their health conditions, treatment requirements, and potential risks, enabling personalized care plans that can improve patient management and lower costs.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product Outlook
  • 2.2.2. Application Outlook
  • 2.2.3. End Use Outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Clinical Risk Grouping Solutions Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising consumer awareness regarding risk management
    • 3.2.1.2. Implementation of big data solutions
    • 3.2.1.3. Increasing focus on AI & Machine Learning
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Patient Data Privacy Concerns
• 3.3. Clinical Risk Grouping Solutions Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Clinical Risk Grouping Solutions Market: Product Estimates & Trend Analysis

• 4.1. Global Clinical Risk Grouping Solutions Market: Product Dashboard
• 4.2. Global Clinical Risk Grouping Solutions Market: Product Movement Analysis
• 4.3. Global Clinical Risk Grouping Solutions Market Estimates and Forecasts, by Product, Revenue (USD Million)
• 4.4. Software
  • 4.4.1. Software market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Private cloud
    • 4.4.2.1. Private cloud market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Public cloud
    • 4.4.3.1. Public cloud market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Hybrid cloud
    • 4.4.4.1. Hybrid cloud market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Services
  • 4.5.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Clinical Risk Grouping Solutions Market: Application Estimates & Trend Analysis

• 5.1. Global Clinical Risk Grouping Solutions Market: Application Dashboard
• 5.2. Global Clinical Risk Grouping Solutions Market: Application Movement Analysis
• 5.3. Global Clinical Risk Grouping Solutions Market by Application, Revenue
• 5.4. Population health management
  • 5.4.1. Population health management market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Chronic disease management
  • 5.5.1. Chronic disease management market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Clinical decision support
  • 5.6.1. Clinical decision support market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Fraud detection and prevention
  • 5.7.1. Fraud detection and prevention market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Other
  • 5.8.1. Other market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Clinical Risk Grouping Solutions Market: End Use Estimates & Trend Analysis

• 6.1. Global Clinical Risk Grouping Solutions Market: End Use Dashboard
• 6.2. Global Clinical Risk Grouping Solutions Market: End Use Movement Analysis
• 6.3. Global Clinical Risk Grouping Solutions Market Estimates and Forecasts, By End Use, Revenue (USD Million)
• 6.4. Hospitals & Clinics
  • 6.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Ambulatory surgical centers
  • 6.5.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Long term care centers
  • 6.6.1. Long term care centers market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Clinical Risk Grouping Solutions Market: Regional Estimates & Trend Analysis by Product, Application and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.3. Mexico
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Vendor Landscape
  • 8.2.1. List of key distributors and channel partners
  • 8.2.2. Key company market share analysis, 2023
  • 8.2.3. Conduent Inc.
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. HBI Solutions
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. 3M
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Cerner (Oracle)
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Optum Inc.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Reveleer
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Nuance Communications, Inc.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Lightbeam
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Health Catalyst
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives

관련자료